You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

AMINOCAPROIC ACID - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for aminocaproic acid and what is the scope of patent protection?

Aminocaproic acid is the generic ingredient in four branded drugs marketed by Epic Pharma Llc, Abraxis Pharm, Baxter Hlthcare, Hospira, Luitpold, Hikma, Amneal, Annora Pharma, Aurobindo Pharma, Belcher, Carnegie, Florida, Sunny, Taro, Tulex Pharms Inc, Vistapharm Llc, Ani Pharms, Edenbridge Pharms, MSN, and Optimus, and is included in twenty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for aminocaproic acid. Twenty suppliers are listed for this compound.

Summary for AMINOCAPROIC ACID
Drug Prices for AMINOCAPROIC ACID

See drug prices for AMINOCAPROIC ACID

Recent Clinical Trials for AMINOCAPROIC ACID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Minia UniversityPhase 3
NYU Langone HealthN/A
Assiut UniversityPhase 4

See all AMINOCAPROIC ACID clinical trials

Pharmacology for AMINOCAPROIC ACID
Drug ClassAntifibrinolytic Agent
Physiological EffectDecreased Fibrinolysis
Medical Subject Heading (MeSH) Categories for AMINOCAPROIC ACID
Anatomical Therapeutic Chemical (ATC) Classes for AMINOCAPROIC ACID

US Patents and Regulatory Information for AMINOCAPROIC ACID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Florida AMINOCAPROIC ACID aminocaproic acid SOLUTION;ORAL 215510-001 Mar 23, 2022 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Taro AMINOCAPROIC ACID aminocaproic acid SOLUTION;ORAL 214458-001 Mar 24, 2023 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ani Pharms AMINOCAPROIC ACID aminocaproic acid TABLET;ORAL 211629-001 Dec 14, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.